Mike the Pike Productions, Inc. (Pink Sheets: MIKP) (www.mtpprods.com) proudly announces Holt McCallany ('Alien 3,' 'Fight Club') in the lead role of its sci-fi thriller, ‘White Space.’ ‘White Space’ is a thriller with a strong ensemble cast including Zulay Henao (‘Fighting,’ ‘Taken’), Jimmy Devoti, Dave Sheridan, Kodi Kitchen, Mike Genovese, Tiffany Brouwer, Jocko Sims and Max Charles, who plays young Peter Parker in the upcoming 'The Amazing Spiderman,' among others.

As recently announced in Variety, “McCallany plays the captain of a deep space fishing vessel that goes on the hunt for a mythic creature in an unexplored region of the galaxy.” McCallany was recently added to the cast of 'The Gangster Squad,' alongside Ryan Gosling, Emma Stone and Josh Brolin.

‘White Space’ was written by Clay McLeod Chapman, directed by Ken Locsmandi with Ryan Colucci, Jim Devoti and Mark B. Newbauer producing. The film is currently in post-production with full-service post and visual effects provided by www.filmworksfx.com. It is the first on a slate of MIKP films including ‘The Skin Trade,’ based on award winning author George R.R. Martin’s novella by the same name. Martin is the author/creator behind HBO’s Emmy Nominated ‘Game of Thrones.’

More ‘White Space’ news to come as well as developments in Spokefish, MIKP’s Graphic Novel division in partnership with Spoke Lane Entertainment.

Check out IPOdesktop’s Mike the Pike Productions Analyst Report http://www.gaskinsco.com/linkto-mikp.shtml

Want more than just press releases? Check out our blog! http://blog.mtpprods.com

Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.